Cipla’s recent inhaler approval of generic of Proventil from the USFDA would aid in strong earnings visibility in the near term. from Markets-Economic Times https://ift.tt/2xaxGWg
I have just started learning Value investing... Really its a great information. Thanks for sharing.
ReplyDeleteBata India Limited
Batliboi Limited
Bayer CropScience Limited
BCC Fuba India Limited